(Q37697608)

English

A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction

scientific article published on 24 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

0 references

1 reference

based on heuristic

inferred from title

0 references

author name string

Juan W Valle

1

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Anne Armstrong

2

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Chris Newman

3

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Valery Alakhov

4

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Grzegorz Pietrzynski

5

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Julie Brewer

6

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Sue Campbell

7

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Pippa Corrie

8

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Eric K Rowinsky

9

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Malcolm Ranson

10

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1029-1037

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

https://scigraph.springernature.com/pub.10.1007/s10637-010-9399-1

0 references

The translocation mechanism of P-glycoprotein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How can we best use structural information on P-glycoprotein to design inhibitors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple molecular mechanisms for multidrug resistance transporters

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer of the gastroesophageal junction: Current therapy options

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological strategies for overcoming multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oesophageal cancer: new developments in systemic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastroesophageal junction adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rising incidence of adenocarcinoma of the esophagus and gastric cardia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How do we improve outcomes for gastric cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pluronic P85 on ATPase activity of drug efflux transporters

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20179989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-010-9399-1

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37697608&oldid=1723509517"